Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by a variety of symptoms affecting communication, behavior, and social interaction. Individuals with ASD may struggle with understanding social cues, engaging in reciprocal conversations, and may exhibit repetitive behaviors or restricted interests. The spectrum nature of the disorder means it can vary widely in severity and manifestation, ranging from highly functional and articulate individuals to those who may require substantial support. Early diagnosis and intervention are crucial, as they can significantly improve developmental outcomes and enhance the quality of life for individuals with ASD.
At TrueBinding, our mission is to discover and develop innovative therapies to enhance the quality of life for patients. Clinical trials are essential for identifying potential new treatments that can improve health and save lives. We deeply value the contributions of patients, families, hospitals, and clinics involved in testing our potential therapies through clinical trials. Each participant plays a crucial role in advancing our understanding of diseases and may help improve outcomes for patients worldwide.
Autism Spectrum Disorder
Dr. Richard Frye is a Child Neurologist with expertise in neurodevelopmental and neurometabolic disorders. He received an MD and PhD in Physiology and Biophysics from Georgetown University. He completed a residency in Pediatrics at the University of Miami, Residency in Child Neurology and Fellowship in Behavioral Neurology and Learning Disabilities at Harvard University/Children’s Hospital Boston and Fellowship in Psychology at Boston University.
Dr. Rossignol, MD FAAFP is a board-certified family physician. He received his Doctorate of Medicine at the Medical College of Virginia and completed his residency in family medicine at the University of Virginia. Dr. Rossignol is a Fellow of the American Academy of Family Physicians (FAAFP) and a Fellow of the Medical Academy of Pediatric Special Needs (FMAPS).
Join Our Clinical Trial
Seeking Participants for ongoing Adult Autism Spectrum Disorder study
We are conducting a study to examine the effectiveness and safety of a novel infusion therapy on syndrome of ASD in Adults (18 –35 years of age) with ASD. For more information, you can check it on clinicaltrials.gov.
If you are interested, please fill out the form below or email info@autismdiscovery.org